Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Medical Hypotheses
|
March 7, 2012
Glutamate-based depression GBD
Dennis J McCarthy, Robert Alexander, Mark A Smith, et al.
Cephalalgia : an International Journal of Headache
|
February 23, 2013
A PET study with [11C]AZ10419369 to determine brain 5-HT1B receptor occupancy of zolmitriptan in healthy male volunteers
Katarina Varnäs, Aurelija Jučaite, Dennis J McCarthy, et al.
Translational Psychiatry
|
August 4, 2019
Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies
Lucia Carboni, Dennis J McCarthy, Bruno Delafont, et al.
Psychopharmacology
|
December 26, 2016
GABA<sub>A</sub> receptor occupancy by subtype selective GABA<sub>Aα2,3</sub> modulators: PET studies in humans
Aurelija Jucaite, Zsolt Cselényi, Jaakko Lappalainen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 8, 2005
Synthesis and biodistribution of radiolabeled alpha 7 nicotinic acetylcholine receptor ligands
Martin G Pomper, Eifion Phillips, Hong Fan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 3, 2016
Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate
Darragh Downey, Arpan Dutta, Shane McKie, et al.
Nuclear Medicine and Biology
|
May 18, 2013
Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor
Hayden T Ravert, Peter Dorff, Catherine A Foss, et al.
Neuroimage
|
April 25, 2008
[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain
M Edward Pierson, Jan Andersson, Svante Nyberg, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 29, 2011
2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity
Dean G Brown, Donna L Maier, Mark A Sylvester, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Medical Hypotheses
|
March 7, 2012
Glutamate-based depression GBD
Dennis J McCarthy, Robert Alexander, Mark A Smith, et al.
Cephalalgia : an International Journal of Headache
|
February 23, 2013
A PET study with [11C]AZ10419369 to determine brain 5-HT1B receptor occupancy of zolmitriptan in healthy male volunteers
Katarina Varnäs, Aurelija Jučaite, Dennis J McCarthy, et al.
Translational Psychiatry
|
August 4, 2019
Biomarkers for response in major depression: comparing paroxetine and venlafaxine from two randomised placebo-controlled clinical studies
Lucia Carboni, Dennis J McCarthy, Bruno Delafont, et al.
Psychopharmacology
|
December 26, 2016
GABA<sub>A</sub> receptor occupancy by subtype selective GABA<sub>Aα2,3</sub> modulators: PET studies in humans
Aurelija Jucaite, Zsolt Cselényi, Jaakko Lappalainen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 8, 2005
Synthesis and biodistribution of radiolabeled alpha 7 nicotinic acetylcholine receptor ligands
Martin G Pomper, Eifion Phillips, Hong Fan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
May 3, 2016
Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate
Darragh Downey, Arpan Dutta, Shane McKie, et al.
Nuclear Medicine and Biology
|
May 18, 2013
Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor
Hayden T Ravert, Peter Dorff, Catherine A Foss, et al.
Neuroimage
|
April 25, 2008
[11C]AZ10419369: a selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain
M Edward Pierson, Jan Andersson, Svante Nyberg, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 29, 2011
2,6-Disubstituted pyrazines and related analogs as NR2B site antagonists of the NMDA receptor with anti-depressant activity
Dean G Brown, Donna L Maier, Mark A Sylvester, et al.
Page
of 1